Try The Drug Club risk-free for 30 days Trial terms

Potassium chloride — Membership Pricing

Potassium chloride is not confirmed for no-additional-cost pricing. Membership pricing may be available; confirm the price with the dispensing pharmacy.

Potassium chloride Pricing

Pricing typePrice
TheDrugClubMembership pricing may be available
Typical Retail$189.00

Membership pricing may be available; confirm the price with the dispensing pharmacy.

About Potassium chloride

Potassium chloride is a prescription medication. Ask your doctor if Potassium chloride is right for you.

Other strengths and forms of Potassium chloride

Conditions Treated with Potassium chloride

How to Check Potassium chloride Pricing

  1. Join TheDrugClub for $19.95/month
  2. Receive your member card by email
  3. Present your card at a participating pharmacy
  4. Check active-formulary eligibility or available membership pricing

Potassium chloride at Participating Pharmacies

Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.

What Potassium chloride is approved for (FDA label)

Potassium Chloride is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. Potassium Chloride is a potassium salt indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. ( 1 )

Source: Read the full FDA label on DailyMed. Label effective date: August 24, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Dosage forms and strengths for Potassium chloride (FDA label)

Each pouch contains 1.5 g of potassium chloride supplying 20 mEq of potassium and 20 mEq of chloride. • Potassium Chloride for Oral Solution, USP 20 mEq: Each pouch contains 1.5 g of Potassium Chloride providing potassium 20 mEq and chloride 20 mEq. ( 3 )

Source: FDA prescribing information (DailyMed). Set ID: ea55ded1-e076-43de-ad3c-c75e7d0a4ebc. Label effective date: August 24, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Potassium chloride (FDA label)

The most common adverse reactions to oral potassium salts are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. Most common adverse reactions are nausea, vomiting, flatulence, abdominal pain/discomfort, and diarrhea. ( 6 ) To report SUSPECTED ADVERSE REACTIONS, contact Advagen Pharma Ltd, at 866-488-0312 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .

Source: FDA prescribing information (DailyMed). Set ID: ea55ded1-e076-43de-ad3c-c75e7d0a4ebc. Label effective date: August 24, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Potassium chloride (FDA label)

Potassium chloride is contraindicated in patients on potassium sparing diuretics. • Concomitant use with potassium sparing diuretics. ( 4 )

Source: FDA prescribing information (DailyMed). Set ID: ea55ded1-e076-43de-ad3c-c75e7d0a4ebc. Label effective date: August 24, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Warnings and precautions for Potassium chloride (FDA label)

• Gastrointestinal Irritation: Dilute before use, take with meals ( 5.1 ) 5.1 Gastrointestinal Irritation May cause gastrointestinal irritation. Increased dilution of the solution and taking with meals may reduce gastrointestinal irritation [see Dosage and Administration (2.1) ] .

Source: FDA prescribing information (DailyMed). Set ID: ea55ded1-e076-43de-ad3c-c75e7d0a4ebc. Label effective date: August 24, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Potassium chloride (FDA label)

• Potassium sparing diuretics: Avoid concomitant use ( 7.1 ) • Renin-angiotensin-aldosterone inhibitors: Monitor for hyperkalemia ( 7.2 ) • Nonsteroidal Anti-Inflammatory drugs: Monitor for hyperkalemia ( 7.3 ) 7.1 Potassium-Sparing Diuretics Use with potassium-sparing diuretics can produce severe hyperkalemia. Avoid concomitant use. 7.2 Renin-Angiotensin-Aldosterone System Inhibitors Drugs that inhibit the renin-angiotensin-aldosterone system (RAAS) including angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), spironolactone, eplerenone, or aliskiren produce potassium retention by inhibiting aldosterone production. Closely monitor potassium in patients receiving concomitant RAAS therapy. 7.3 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) NSAIDS may produce potassium retention by reducing renal synthesis of prostaglandin E and impairing the renin-angiotensin system. Closely monitor potassium in patients on concomitant NSAIDs.

Source: FDA prescribing information (DailyMed). Set ID: ea55ded1-e076-43de-ad3c-c75e7d0a4ebc. Label effective date: August 24, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Start Your Risk-Free Trial
Start Your Risk-Free Trial